Skip to content

Clinical trials

Completed Phase 2 Epstein-Barr Virus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epstein-Barr Virus Infections Phase: Phase 2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20092
20102
20111
20141
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Baylor College of Medicine1
Celgene1
Chinese University of Hong Kong1
Dana-Farber Cancer Institute1
Henogen1
Massachusetts General Hospital1
National Institute of Allergy and Infectious Diseases (NIAID)1
University of Giessen1
University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epstein-Barr Virus Infections11
Nasopharyngeal Carcinoma3
Acquired Immunodeficiency Syndrome2
Cytomegalovirus Infections2
Nasopharyngeal Neoplasms2
Recurrence2
AIDS-Related Opportunistic Infections1
HIV Infections1
Head and Neck Neoplasms1
Herpesviridae Infections1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.